Ascendis Pharma A/S Tax Expense Income At Applicable Tax Rate
Ascendis Pharma A/S (ASND) reported Tax Expense Income At Applicable Tax Rate of EUR 46.78 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-02-11.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:TaxExpenseIncomeAtApplicableTaxRate · last filed 2026-02-11
| Period end | Tax Expense Income At Applicable Tax Rate 12 month | Tax Expense Income At Applicable Tax Rate 12 month as first filed |
|---|---|---|
| 2025-12-31 | 46.78M EUR 20-F · filed 2026-02-11 | |
| 2024-12-31 | 82.11M EUR 20-F · filed 2026-02-11 | |
| 2023-12-31 | 104.31M EUR 20-F · filed 2026-02-11 | |
| 2022-12-31 | 127.12M EUR 20-F · filed 2025-02-12 | |
| 2021-12-31 | 84.47M EUR 20-F · filed 2024-02-07 | |
| 2020-12-31 | 92.22M EUR 20-F · filed 2023-02-16 | |
| 2019-12-31 | 48.02M EUR 20-F · filed 2022-03-02 | |
| 2018-12-31 | 28.71M EUR 20-F · filed 2021-03-10 | |
| 2017-12-31 | 27.36M EUR 20-F · filed 2020-04-03 | -27.36M EUR 20-F · filed 2018-03-28 |
| 2016-12-31 | 15.12M EUR 20-F · filed 2019-04-03 | -15.12M EUR 20-F · filed 2018-03-28 |
| 2015-12-31 | -7.89M EUR 20-F · filed 2018-03-28 |